Women with diminished ovarian reserve are at higher risk of experiencing recurrent pregnancy loss, with low antimüllerian hormone levels and antral follicle count predictive of miscarriage, according to a recent study.
Fertility history, particularly a previous tubal ectopic pregnancy (TEP), does not appear to have any effect on the probability of a live birth following in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) in women with tubal factor infertility, a study has shown.
Higher dietary protein intake was associated with a lower risk of developing atrial fibrillation (AF) in postmenopausal women compared with lower protein intake, according to a secondary analysis presented at the ACC.20/WCC Virtual Meeting.
Perineal interferential current (IC) proves beneficial in the treatment of women with premature ovarian insufficiency (POI) who are using systemic hormone therapy (HT) and presenting with sexual complaints, with the results of a 4-week trial showing that IC yields favourable effects on pain, lubrication, satisfaction and orgasm as compared with topical estriol.
High-dose vitamin D supplementation (2,800 IU/day) during pregnancy may improve bone mineralization, specifically bone mineral content (BMC) and bone mineral density (BMD), in offspring during the first 6 years of life, according to a prespecified secondary analysis of a study from Denmark.
Pneumonia caused by the coronavirus disease 2019 (COVID-19) in pregnant women shows similar clinical characteristics to that in nonpregnant adult patients with the same condition, according to a recent study.
The selective neurokinin 3 receptor antagonist fezolinetant induces rapid reductions in moderate-to-severe menopausal vasomotor symptoms (VMS) with a tolerable safety profile, according to the results of a phase IIb trial.
A recent study reports a mean growth rate of proximal aorta of about 0.1 mm/year in hypertensive patients with known aortic dilatation. In addition, those with increased rather than normal aortic z score have slower dilatation over time.
Among patients with nonvalvular atrial fibrillation (AF), treatment with apixaban was associated with a lower rate of ischaemic stroke, systemic embolism, and major bleeding compared with rivaroxaban, according to a large study assessing patients in routine care.